verified_user
Standardful
首页chevron_right标准chevron_rightGMP(cGMP)
有效国际标准update 最后更新:持续更新

GMP(cGMP)

药品生产质量管理规范——WHO 指南与 FDA 21 CFR 210/211

apartment发布组织:世界卫生组织(WHO)/ 美国食品药品监督管理局(FDA)

标准简介

药品生产质量管理规范(GMP,在美国称为 cGMP——当前良好生产规范)是确保药品、医疗器械、食品和化妆品在受控条件下生产并符合质量标准的一系列生产和质量控制准则。GMP 由世界卫生组织(WHO)在国际层面制定指南,美国食品药品监督管理局(FDA)通过 21 CFR 210/211 在美国强制执行,欧盟通过 EudraLex 第 4 卷执行。GMP 的核心理念是质量不能仅靠检验来保证,而必须融入到整个生产过程中。

GMP 要求涵盖多个关键领域:人员资质和培训、厂房和设施条件、设备维护和校准、原材料控制和供应商管理、生产过程控制和验证、质量控制和实验室测试、文件和记录保存(数据完整性)、包装和标签控制、储存和分销条件以及投诉处理和产品召回程序。FDA 的 cGMP 检查重点关注数据完整性(ALCOA+ 原则:可归属、易读、同期记录、原始、准确、完整、一致、持久、可获取)。不合规可能导致 FDA 警告信、进口禁令(Import Alert)、同意令、产品召回或刑事起诉。WHO 预认证计划要求药品制造商通过 GMP 检查方可向联合国机构供应药品。

science

Quality Assurance Framework

Ensures pharmaceutical and food products are consistently produced and controlled according to quality standards appropriate to their intended use.

public

Global Regulatory Foundation

Over 100 countries have incorporated WHO GMP provisions into their national medicines laws. The FDA enforces cGMP through 21 CFR Parts 210 and 211.

verified

Production & Control Standards

Covers personnel qualification, facility design, equipment validation, raw material controls, production processes, quality control testing, and documentation.

list_alt Core GMP Principles

  • Personnel qualification, training, and hygiene
  • Premises and equipment design and maintenance
  • Documentation and record keeping
  • Production process validation and control
  • Quality control and laboratory testing
  • Complaint handling and product recalls
  • Self-inspection and quality audits
  • Sanitation and contamination prevention

Who Needs to Comply?

groups

Manufacturers of pharmaceutical products, active pharmaceutical ingredients (APIs), biologicals, vaccines, medical devices, food products, and cosmetics. Required by virtually every national regulatory authority worldwide.

Key Requirements

1

Quality Management System

Establish a comprehensive quality management system covering production and quality control, with a designated quality unit independent of production responsible for release of finished products.

2

Process Validation

Validate manufacturing processes to demonstrate they consistently produce product meeting predetermined specifications and quality attributes. Maintain ongoing process verification.

3

Documentation & Records

Maintain complete batch production records, equipment logs, laboratory records, and standard operating procedures. All records must be contemporaneous, attributable, and indelible.

4

Facility & Equipment Controls

Design and maintain facilities and equipment to prevent contamination, mix-ups, and errors. Implement qualification protocols (IQ/OQ/PQ) for critical equipment.

5

Quality Control Testing

Operate adequately equipped laboratories with trained personnel to test raw materials, intermediates, and finished products against established specifications before release.

Penalties & Enforcement

warning

FDA penalties include warning letters, product seizures, injunctions, facility shutdowns, consent decrees, and criminal prosecution. Adulterated drugs under 21 USC 331 can result in fines up to $500,000 and imprisonment up to 3 years. WHO prequalification loss bars products from UN procurement.

官方文档

查看全部

实施时间线

gavel
1962年
US Congress mandates FDA to require GMP for drugs (Kefauver-Harris Amendment)
public
1969年
WHO publishes first GMP guidelines as part of Certification Scheme
description
1978年
FDA finalizes 21 CFR Parts 210 and 211 (cGMP for finished pharmaceuticals)
science
2000年
ICH Q7 GMP guide for Active Pharmaceutical Ingredients published
update
2014年
WHO TRS 986 Annex 2 updated GMP guidelines published
new_releases
2025年
FDA issues updated guidance on pharmaceutical CGMP practices

相关分类